03 · What You Need to Know
Understanding How Explanatory Trial Design Influences External Validity
What Makes a Trial Explanatory?
An explanatory trial is oriented toward clarifying whether an intervention produces an intended effect under conditions selected to support or isolate its efficacy.
Researchers may use selected participants, specialist providers, carefully specified procedures, and intensive implementation monitoring.
For example, an educational intervention may be evaluated using trained facilitators who deliver identical instructional activities to students meeting narrowly defined preparation criteria.
Such arrangements may help establish the effect of the intervention under those conditions.
However, explanatory trials are not defined by a single methodological requirement. They may combine explanatory and pragmatic characteristics across different design domains.
The distinction is discussed in explanatory versus pragmatic trial design.
What Is Real-World Applicability?
Real-world applicability concerns whether a study's findings are relevant to populations, settings, treatment strategies, and decisions beyond the immediate trial.
It overlaps with external validity, generalizability, and transportability, although these terms describe related but distinct inferential questions.
Generalizability commonly concerns extending results to a target population, while transportability concerns applying causal evidence to a different population or setting under suitable assumptions.
Applicability also involves practical considerations such as staffing, affordability, infrastructure, and organizational capacity.
A credible effect estimate within a trial does not automatically establish that the same effect would occur under substantially different implementation conditions.
How Can Explanatory Design Reduce Applicability?
Explanatory design choices may restrict the circumstances represented by the trial.
For example, excluding participants with complex needs may produce a sample that differs from ordinary intervention recipients.
Using highly trained providers may establish the effect of a treatment delivered by specialists rather than the effect achievable through ordinary staff.
Intensive monitoring may improve delivery consistency but require resources unavailable during routine implementation.
These differences do not invalidate the original estimate. They limit the conditions to which the findings can be extended without additional evidence.
What Is the Difference Between Internal and External Validity?
Internal validity
The credibility of the causal effect estimate for the population and treatment conditions studied.
External validity
The extent to which findings can support conclusions about relevant populations, settings, or conditions beyond the study.
A trial can have strong internal validity but limited external validity for a particular adoption decision.
For example, randomization and blinded assessment may support a credible estimate of an intervention delivered by specialist instructors.
However, that estimate may not directly answer whether ordinary instructors can achieve comparable outcomes.
Conversely, conducting a study under routine conditions does not automatically establish internal validity.
Both forms of validity require attention to their respective assumptions and evidence.
Which Explanatory Design Choices May Limit Applicability?
| Design choice |
Potential applicability limitation |
Question for researchers |
| Restrictive eligibility |
Participants differ from ordinary recipients. |
Would excluded individuals normally receive the intervention? |
| Specialist providers |
Ordinary practitioners may lack equivalent skills. |
Is specialist expertise essential to the treatment strategy? |
| Intensive supervision |
Implementation support may be difficult to sustain. |
Would future implementers receive comparable support? |
| Fixed delivery procedures |
Routine providers may need to adapt treatment. |
Which procedures are essential and which can vary? |
| Restricted background services |
Comparison conditions may differ from ordinary practice. |
Would participants normally receive additional services? |
| Highly selected settings |
Institutions may have unusually favorable resources. |
Do target institutions have comparable capacity? |
| Specialized outcome measures |
Measured improvements may not represent practical benefits. |
Does the outcome reflect the intended adoption decision? |
These are potential limitations, not automatic defects. Their importance depends on the intervention and the target population or setting.
Why Can Restrictive Eligibility Be Problematic?
Eligibility restrictions may select participants with characteristics associated with treatment response.
For example, a digital learning intervention tested only among students with high digital literacy may not provide sufficient evidence about students who require additional technical support.
However, restrictive eligibility can be appropriate when the intervention is intended only for a defined population or when exclusions are justified by safety.
The relevant question is whether the trial population corresponds to the population for whom the findings will be used.
Researchers should distinguish scientifically justified restrictions from those introduced mainly to simplify implementation.
How Can Specialist Providers Affect Applicability?
Some interventions depend on specialized knowledge or professional judgment.
An explanatory trial may use expert providers to establish whether the intervention can work when delivered competently.
However, an institution considering routine adoption may rely on practitioners with different training and experience.
If provider competence influences intervention outcomes, the effect observed under specialist delivery may differ from the effect under ordinary staffing arrangements.
Researchers should determine whether specialist expertise is an essential component or a research-specific support.
Where appropriate, provider competence should be assessed rather than inferred from professional qualifications alone.
Can Intensive Implementation Support Change What Was Tested?
Yes. Training, supervision, reminders, and technical assistance may influence how consistently an intervention is delivered and received.
For example, an AI-assisted writing program may achieve high participation when students receive individualized reminders and instructors receive weekly coaching.
If these supports are unavailable during ordinary adoption, the intervention package implemented in practice may differ from the one evaluated.
However, removing support is not always appropriate. Some interventions require ongoing assistance to function effectively.
Researchers should define whether implementation support belongs to the treatment strategy and report its resource requirements.
Does Tight Intervention Standardization Reduce External Validity?
It may when the standardized procedures differ from how the intervention would ordinarily be delivered.
For example, requiring identical instructional examples across academic disciplines may create an intervention less responsive to local learning needs.
However, some interventions require consistent procedures to preserve essential functions or safety.
Researchers should distinguish necessary standardization from restrictions introduced mainly for research convenience.
The relationship is examined further in intervention standardization and real-world applicability.
Can Highly Controlled Comparison Conditions Reduce Applicability?
Yes. An explanatory trial may restrict additional services to isolate a particular treatment contrast.
However, ordinary participants may receive several forms of support simultaneously.
For example, students may use tutoring, instructor consultations, and digital resources alongside a new learning program.
If these services are prohibited during the trial but ordinarily available during implementation, the observed effect may not represent the incremental benefit of adopting the program within existing services.
Researchers should define whether the intervention is intended to replace, supplement, or operate alongside usual practice.
How Can Outcome Selection Limit Applicability?
An explanatory trial may use outcomes closely aligned with a proposed mechanism.
For example, researchers may assess whether students can identify weaknesses in AI-generated research arguments immediately after training.
That outcome may provide useful evidence about a targeted skill.
However, universities may be more interested in whether students subsequently produce stronger independent research proposals.
Improvement in a proximal measure does not automatically establish improvement in a consequential outcome.
Researchers should consider the importance of decision-relevant outcomes when interpreting applicability.
Does a Positive Efficacy Result Establish Real-World Effectiveness?
Not necessarily. Efficacy and effectiveness concern effects under potentially different conditions.
An intervention may produce meaningful benefits when delivered with intensive support but smaller effects under ordinary implementation.
However, smaller real-world effects are not inevitable.
Some interventions may perform similarly across settings, while others may benefit from contextual adaptations or existing support systems.
Researchers should avoid assuming a universal efficacy-effectiveness gap.
The distinction between efficacy and effectiveness trials should guide claims about the conditions under which effects have been demonstrated.
Can Researchers Generalize From an Explanatory Trial?
Potentially. Generalization is not prohibited simply because a trial is explanatory.
Researchers should identify the target population and determine whether differences from the trial population are relevant to treatment effects.
For example, if an intervention's effect does not meaningfully depend on a particular baseline characteristic, differences in that characteristic may have limited consequences for transportability.
However, such assumptions require justification.
Statistical generalization and transportability methods may help when relevant effect modifiers are measured and the necessary identification conditions are plausible.
These methods cannot automatically overcome unmeasured differences or unsupported assumptions about treatment effects.
What Is Transportability in Causal Inference?
Transportability concerns using evidence from one population or setting to estimate causal effects in another.
For example, researchers may wish to estimate how an intervention evaluated in specialist-supported universities would perform in institutions with different student populations.
Transportability requires assumptions about the relationship between trial and target populations, including relevant effect modifiers and treatment strategies.
Methods such as weighting or outcome modeling may be useful under suitable conditions.
However, statistical adjustment cannot automatically make different interventions or implementation systems equivalent.
Researchers should distinguish population transportability from changes in the treatment package itself.
Does Multi-Site Recruitment Automatically Improve Applicability?
No. Including several institutions may broaden the settings represented, but the participating sites may still be unusually well resourced or otherwise selected.
For example, ten universities with advanced digital infrastructure may provide limited evidence about institutions with unreliable connectivity.
Researchers should examine the characteristics of participating sites and their relationship to the intended implementation settings.
Site diversity may be informative when it captures relevant contextual variation.
However, the number of sites alone does not establish external validity.
Can Researchers Preserve Internal Validity While Improving Applicability?
Yes. Many design choices intended to support applicability are compatible with rigorous causal inference.
For example, researchers may recruit a broader target population, use ordinary intervention providers, and permit appropriate delivery adaptation while retaining randomization and blinded outcome assessment.
However, some choices may introduce practical challenges involving contamination, recruitment, missing outcomes, or treatment heterogeneity.
These challenges should be addressed through design and analysis rather than assuming that greater pragmatism necessarily reduces rigor.
Researchers should distinguish controls necessary for valid inference from controls that alter the treatment strategy being evaluated.
How Does PRECIS-2 Help?
PRECIS-2 assesses how trial design choices align with explanatory or pragmatic objectives across nine domains.
These include eligibility, recruitment, setting, organization, flexibility of delivery, flexibility of adherence, follow-up, primary outcome, and primary analysis.
The tool can help researchers identify design choices that may be more restrictive than the intended practical question requires.
However, PRECIS-2 is not a direct measure of external validity.
A more pragmatic profile does not automatically establish that the study findings apply to every target setting.
The tool is most useful when applied prospectively to improve alignment between trial purpose and design.
Should Researchers Always Make Trials More Pragmatic?
No. The appropriate trial orientation depends on the uncertainty being investigated.
If researchers do not yet know whether an intervention can produce its intended effect under specified conditions, an explanatory study may be justified.
If the intervention already has supporting evidence and the main uncertainty concerns routine adoption, a more pragmatic evaluation may be informative.
However, there is no universal requirement that explanatory evidence must always precede pragmatic evidence.
The choice should reflect existing knowledge, feasibility, ethical considerations, and the intended decision.
How Can Researchers Improve Applicability Without Redesigning the Entire Trial?
Researchers may improve the relevance of explanatory evidence through careful reporting and complementary studies.
For example, they can document participant selection, provider qualifications, implementation support, resource requirements, and contextual conditions.
They may also conduct feasibility studies in target settings or evaluate whether ordinary providers can reproduce essential intervention functions.
However, reporting alone does not establish effectiveness under untested conditions.
When important differences remain between the studied and target treatment strategies, further empirical evaluation may be necessary.
How Should Researchers Report Applicability Limitations?
Reports should describe the population, settings, intervention delivery, comparison condition, and outcome measures actually studied.
Researchers should identify important differences between these conditions and the intended implementation environment.
For example, a trial using specialist instructors and intensive supervision should not claim that ordinary faculty can achieve the same results without supporting evidence.
Limitations should be specific rather than reduced to a generic statement that generalizability may be limited.
The discussion should explain which aspects of applicability are supported, uncertain, or outside the study's scope.
